You searched for "PPE"

719 results found

The COVID-19 ‘frontlines’: a foundation doctor’s perspective

Staring through the fragmented stained glass of the Virgin Mary and her assorted angels, I reflected on the strangeness of the workplace I now found myself working in and the irony of a workforce now working together more enthusiastically than...

Endophthalmitis after intravitreal anti-VEGF injection

The authors report the results of a retrospective multicentre study conducted at 17 retina referral centres to investigate the microbial spectrum of endophthalmitis after anti-VEGF injections. A total of 83 cases of culture-positive endophthalmitis (58.4%) were included. The most frequent...

Ocular toxicity secondary to deferoxamine

Patients with myelodysplastic syndromes can develop transfusion-related iron overload as they become dependent on recurrent blood transfusions [1]. Iron chelation therapy is indicated for the treatment of iron overload and one established example of this is deferoxamine. However, deferoxamine ocular...

Redeployment during the COVID-19 pandemic: personal accounts from four ophthalmology trainees

We once believed that the coronavirus would not penetrate the safe confines of the United Kingdom, like so many outbreaks before this. Once the news came that this pandemic descended into our hospitals, the anxieties about redeployment began. Many of...

Lessons from an unusual case of syphilis

The rise of syphilis transmission rates over the past two decades has been one of public health’s great puzzles. In the UK, the situation has reached epidemic levels, with a 126% increase between 2013 and 2018 [1]. We present a...

Retina Subspecialty Day highlights from the RCOphth 2026 Annual Congress

Implementation of biosimilars in NHS retinal services A NHS England (NHSE) perspective Luke Nicholson (Moorfields Eye Hospital) explained that the NHSE perspective overall is structured on best value medicine for the patient and system, accounting for a finite budget and...

Burning vision: vision loss from misuse of ‘toy’ laser pens in children

A case series of five children with macular burns due to the misuse of novelty laser products, purchased online or abroad, was undertaken at the Royal Hallamshire Hospital and The Children’s Hospital, Sheffield [1]. All patients were from the Sheffield...

Haag-Streit UK announces attendance at RCOphth Annual Congress 2025

Haag-Streit UK will be exhibiting at the RCOphth Annual Congress 2025 on 19th-22nd May at the ACC in Liverpool. Visit stand 53 to see key products from the HS-UK portfolio, including the BQ 900 slit lamp with 3D imaging, a...

Haag-Streit slit lamps – a fantastic investment for every clinic

Haag-Streit slit lamps have earned a legendary reputation for their unmatched quality, precision, clinical reliability, durability, and cost-efficiency. The purchase of a Haag-Streit slit lamp represents a long-term investment in outstanding, future-proof technology. NHS supply chain reference Haag-Streit as the...

Haag-Streit UK announces new topography module for SOLIX (June 2025)

Bishop’s Stortford, UK – 11th June 2025 - Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, has announced that SOLIX has a new topography module. SOLIX delivers...

Haag-Streit UK announces new topography module for SOLIX

The Optovue SOLIX is a Full Range OCT system with a comprehensive list of applications and unsurpassed imaging. Featuring multiple tools, it enables clinicians to identify and manage numerous pathologies from the front to the back of the eye. SOLIX...

SCONe Project seeks participants for patient and public involvement group to revolutionise AMD research

The SCONe project, run by optometrists, ophthalmologists, and researchers from the University of Edinburgh, and funded by Sight Scotland, is appealing for participants to take part in a Patient and Public Involvement (PPI) group focused on revolutionising the detection and management of Age-Related Macular Degeneration (AMD).